Ian S Hagemann

19PUBLICATIONS
187CO-AUTHORS
Tumour immunologyMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 21, 2026
Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis.

|Feb 06, 2026
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial.

Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang

|Jan 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Tim Kong, Alex Mabry, Maureen Highkin

|Oct 03, 2025
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model.

Yukihide Ota, Vijayalaxmi Gupta, Bisiayo E Fashemi

|Aug 14, 2025
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.

Andrew A Davis, Ellen Jaeger, Ian S Hagemann

|Feb 26, 2025
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer.

Andrea R Hagemann, Ian S Hagemann, David G Mutch

Pageof 4

Frequent Collaborators

5 joint publications

Foluso O Ademuyiwa

3 joint publications

Ron Bose

3 joint publications

Jingqin Luo

3 joint publications

David G Mutch